Radiolabeled metaiodobenzylguanidine for imaging and therapy of neuroblastoma.
about
123I-MIBG scintigraphy and 18F-FDG-PET imaging for diagnosing neuroblastoma2-deoxy-2-((18)F)fluoro-D-glucose positron emission tomography/computed tomography imaging in paediatric oncology.Therapeutic targets for neuroblastomas.Vorinostat increases expression of functional norepinephrine transporter in neuroblastoma in vitro and in vivo model systems.Tumor dosimetry using [124I]m-iodobenzylguanidine microPET/CT for [131I]m-iodobenzylguanidine treatment of neuroblastoma in a murine xenograft model.An evaluation in vitro of PARP-1 inhibitors, rucaparib and olaparib, as radiosensitisers for the treatment of neuroblastoma.Evaluation of Norepinephrine Transporter Expression and Metaiodobenzylguanidine Avidity in Neuroblastoma: A Report from the Children's Oncology Group.Vesicular monoamine transporter protein expression correlates with clinical features, tumor biology, and MIBG avidity in neuroblastoma: a report from the Children's Oncology Group.Relapsed neuroblastomas show frequent RAS-MAPK pathway mutationsThe Na+/I- symporter (NIS): mechanism and medical impact.The biology of the sodium iodide symporter and its potential for targeted gene delivery.MIBG avidity correlates with clinical features, tumor biology, and outcomes in neuroblastoma: A report from the Children's Oncology Group.131I-MIBG targeting of neuroblastoma cells is acutely enhanced by KCl stimulation through the calcium/calmodulin-dependent kinase pathway.Clinical Significance of Pretreatment FDG PET/CT in MIBG-Avid Pediatric Neuroblastoma.
P2860
Q24186888-EDBB7DB8-7D75-4526-AC94-5001D5DE1C9FQ34404416-848BF91F-63D4-437F-B1F1-778D5EF2E9D8Q34560877-55604F5A-DB8E-48B2-AF91-4F8C7E0EF486Q35637861-20D6C0E3-A414-46AC-97D9-EDF4C62087DFQ36013113-274C6A06-D76B-493D-8F99-EE825AB89019Q36102008-F27F856B-5498-47FB-A094-2C705514F79DQ36294179-C317008F-2825-40FB-877D-67BBED407DF0Q36521985-365DD409-928C-4778-8C15-F34EE3C49EEFQ36641925-F27DBCFA-F860-4258-AD6C-DE4582528725Q37494004-1D6B7669-424C-473E-B58E-D2887F1F64A6Q37564872-891F7B36-8C60-4C1D-B87C-4FDD11EDB295Q38850279-15FC3BEF-4952-4320-A206-6AF4AD789132Q39140098-D3A86296-01B2-44FB-B312-AC364ED4AA0DQ47360425-FE8CBF11-D7D4-488C-AFFC-E519AC608979
P2860
Radiolabeled metaiodobenzylguanidine for imaging and therapy of neuroblastoma.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on December 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Radiolabeled metaiodobenzylguanidine for imaging and therapy of neuroblastoma.
@en
Radiolabeled metaiodobenzylguanidine for imaging and therapy of neuroblastoma.
@nl
type
label
Radiolabeled metaiodobenzylguanidine for imaging and therapy of neuroblastoma.
@en
Radiolabeled metaiodobenzylguanidine for imaging and therapy of neuroblastoma.
@nl
prefLabel
Radiolabeled metaiodobenzylguanidine for imaging and therapy of neuroblastoma.
@en
Radiolabeled metaiodobenzylguanidine for imaging and therapy of neuroblastoma.
@nl
P2093
P1476
Radiolabeled metaiodobenzylguanidine for imaging and therapy of neuroblastoma
@en
P2093
P304
P577
2008-12-01T00:00:00Z